Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.3%

1 terminated out of 44 trials

Success Rate

96.0%

+9.5% vs benchmark

Late-Stage Pipeline

20%

9 trials in Phase 3/4

Results Transparency

8%

2 of 24 completed with results

Key Signals

2 with results96% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (8)
P 1 (1)
P 2 (5)
P 3 (1)
P 4 (8)

Trial Status

Completed24
Recruiting8
Unknown8
Enrolling By Invitation2
Not Yet Recruiting1
Terminated1

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT07370441Phase 4Enrolling By Invitation

Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients

NCT03541785Enrolling By Invitation

Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric AKI

NCT07262320Recruiting

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

NCT06038162Not ApplicableRecruiting

Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients

NCT06285162Recruiting

Analgesia Nociception Index to Explore Autonomic Nervous System in Patients With Continuous Renal Replacement Therapy

NCT07312929Not Yet Recruiting

Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis

NCT03329313Phase 2Recruiting

Effects of Variation of Sodium Dialysate in ICU

NCT05814341Phase 3CompletedPrimary

Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy

NCT04705896Phase 4Recruiting

Albumin To Enhance Recovery After Acute Kidney Injury

NCT06466421Phase 4Completed

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

NCT04132492Completed

AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients

NCT05646615Completed

Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients

NCT06685367Not ApplicableRecruiting

The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI)

NCT05788211Completed

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

NCT04071171Phase 2Completed

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

NCT06226441Not ApplicableRecruiting

Aminoglycoside Administration in Septic Patients

NCT04512131CompletedPrimary

Impact of Dialysis Modality on Coagulation and Platelet Function

NCT03614741Phase 4Unknown

Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients

NCT03636464RecruitingPrimary

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

NCT05666544Not ApplicableUnknown

Renal Replacement Therapies Decision Aids

Scroll to load more

Research Network

Activity Timeline